Mohan Kamthan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohan Kamthan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Asghar Ali
Medicinal Chemistry Laboratory Department of Biosciences Jamia Millia Islamia New Delhi India
6 shared publications Saman Saim Rahman
Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
4 shared publicationsAiysha Siddiq Khan
Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
3 shared publicationsManika Garg
Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
3 shared publicationsMuskan Verma
Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
3 shared publicationsPawan Yadav
Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
3 shared publications
Latest Publications
- Open Access
- 21 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (12) , 1771
Bacteriophages and Their Enzymes: Allies Against Microbial Biofilms
Bacterial biofilms pose a substantial challenge in healthcare and industrial and environmental settings because of their resilience and antibiotic resistance. Biofilm formation is a complex process involving microbial communities encased in an extracellular matrix that contributes to increased resistance and persistent infections. This review explores the emerging roles of bacteriophages and their derived enzymes as promising alternatives or adjunct therapies to combat bacterial biofilms. Bacteriophages, viruses that infect bacteria, exhibit marked specificity and diverse mechanisms for targeting and lysing bacterial cells within biofilms. Enzymes, including endolysins and depolymerases, have demonstrated efficacy in disrupting biofilm matrices. Moreover, the potential synergy between bacteriophages and antibiotics enhances their antimicrobial activity, providing a multifaceted approach for combating biofilm-associated infections. This review critically evaluates the current research, highlighting the successes and limitations of bacteriophage-based strategies in biofilm control, and underscores the potential of these alternatives in shaping future therapeutic interventions against biofilm-related bacterial infections.
- 21 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (12) , 1771
Open AccessBacteriophages and Their Enzymes: Allies Against Microbial Biofilms
Bacterial biofilms pose a substantial challenge in healthcare and industrial and environmental settings because of their resilience and antibiotic resistance. Biofilm formation is a complex process involving microbial communities encased in an extracellular matrix that contributes to increased resistance and persistent infections. This review explores the emerging roles of bacteriophages and their derived enzymes as promising alternatives or adjunct therapies to combat bacterial biofilms. Bacteriophages, viruses that infect bacteria, exhibit marked specificity and diverse mechanisms for targeting and lysing bacterial cells within biofilms. Enzymes, including endolysins and depolymerases, have demonstrated efficacy in disrupting biofilm matrices. Moreover, the potential synergy between bacteriophages and antibiotics enhances their antimicrobial activity, providing a multifaceted approach for combating biofilm-associated infections. This review critically evaluates the current research, highlighting the successes and limitations of bacteriophage-based strategies in biofilm control, and underscores the potential of these alternatives in shaping future therapeutic interventions against biofilm-related bacterial infections.
- 4 January 2025
- Published by Elsevier in Life Sciences
- Vol. 362, 123368
Cadmium-induced augmentation of fungal translocation promotes systemic infection in mice via gut barrier disruption and immune dysfunction
- 4 January 2025
- Published by Elsevier in Life Sciences
- Vol. 362, 123368
Cadmium-induced augmentation of fungal translocation promotes systemic infection in mice via gut barrier disruption and immune dysfunction
- 24 October 2024
- Published by Springer Nature
- p. 251-277
Advanced Uses of Quantum Dots in Medical Imaging
- 24 October 2024
- Published by Springer Nature
- p. 251-277
Advanced Uses of Quantum Dots in Medical Imaging
- 23 September 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 280 (Pt 3) , 135977
Structural inscrutabilities of Histone (H2BK123) monoubiquitination: A systematic review
- 23 September 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 280 (Pt 3) , 135977
Structural inscrutabilities of Histone (H2BK123) monoubiquitination: A systematic review
- Open Access
- 18 April 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 277, 116337
Cadmium modulates intestinal Wnt/β-catenin signaling ensuing intestinal barrier disruption and systemic inflammation
- 18 April 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 277, 116337
Open AccessCadmium modulates intestinal Wnt/β-catenin signaling ensuing intestinal barrier disruption and systemic inflammation
- Top Cited PapersOpen Access
- 29 July 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (8) , 1934
Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies
Biofilms are complex communities of microorganisms that grow on surfaces and are embedded in a matrix of extracellular polymeric substances. These are prevalent in various natural and man-made environments, ranging from industrial settings to medical devices, where they can have both positive and negative impacts. This review explores the diverse applications of microbial biofilms, their clinical consequences, and alternative therapies targeting these resilient structures. We have discussed beneficial applications of microbial biofilms, including their role in wastewater treatment, bioremediation, food industries, agriculture, and biotechnology. Additionally, we have highlighted the mechanisms of biofilm formation and clinical consequences of biofilms in the context of human health. We have also focused on the association of biofilms with antibiotic resistance, chronic infections, and medical device-related infections. To overcome these challenges, alternative therapeutic strategies are explored. The review examines the potential of various antimicrobial agents, such as antimicrobial peptides, quorum-sensing inhibitors, phytoextracts, and nanoparticles, in targeting biofilms. Furthermore, we highlight the future directions for research in this area and the potential of phytotherapy for the prevention and treatment of biofilm-related infections in clinical settings.
- 29 July 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (8) , 1934
Top Cited PapersOpen AccessMicrobial Biofilms: Applications, Clinical Consequences, and Alternative Therapies
Biofilms are complex communities of microorganisms that grow on surfaces and are embedded in a matrix of extracellular polymeric substances. These are prevalent in various natural and man-made environments, ranging from industrial settings to medical devices, where they can have both positive and negative impacts. This review explores the diverse applications of microbial biofilms, their clinical consequences, and alternative therapies targeting these resilient structures. We have discussed beneficial applications of microbial biofilms, including their role in wastewater treatment, bioremediation, food industries, agriculture, and biotechnology. Additionally, we have highlighted the mechanisms of biofilm formation and clinical consequences of biofilms in the context of human health. We have also focused on the association of biofilms with antibiotic resistance, chronic infections, and medical device-related infections. To overcome these challenges, alternative therapeutic strategies are explored. The review examines the potential of various antimicrobial agents, such as antimicrobial peptides, quorum-sensing inhibitors, phytoextracts, and nanoparticles, in targeting biofilms. Furthermore, we highlight the future directions for research in this area and the potential of phytotherapy for the prevention and treatment of biofilm-related infections in clinical settings.